The Middle East and Africa (MEA) Neurovascular Catheters market is projected to grow from US$ 78.6 million in 2024 to US$ 148.1 million by 2033, registering a CAGR of 7.6% between 2025 and 2033.
Growth across the region is led by Saudi Arabia, the UAE, and South Africa, supported by expanding hospital infrastructure, government-led initiatives to enhance stroke care, and increasing investment in neuro-interventional suites. In North Africa, countries such as Egypt and Morocco are experiencing rising procedural volumes as urban hospitals upgrade imaging capabilities and strengthen stroke management protocols.
Stroke remains a major cause of mortality across MEA, with ischemic stroke incidence increasing due to aging populations and growing prevalence of hypertension, diabetes, and obesity. As a result, catheter-based interventions — including mechanical thrombectomy for large vessel occlusions and endovascular coil embolization for cerebral aneurysms — are becoming standard practice in tertiary care hospitals, driving demand for thrombectomy and microcatheter systems.
Improvements in healthcare infrastructure, such as hybrid angiography suites and advanced intensive care units, are supporting greater adoption of coated and multi-lumen catheters, particularly in critical care environments. In GCC countries, government healthcare programs and public–private partnerships are enabling procurement of advanced devices and expanding clinician training, further accelerating market uptake. Across the region, hospitals and clinics remain the primary end users, while diagnostic imaging centers and specialized stroke units are gradually expanding their interventional capabilities.
Strategic collaborations between MedTech companies and hospitals, alongside regional clinical studies, are further strengthening market growth by improving access to advanced technologies, enhancing physician expertise, and generating real-world clinical evidence.
Key segments contributing to the MEA Neurovascular Catheters market analysis include product type, coating type, lumen configuration, and end user.
By product, the market is segmented into thrombectomy catheters, embolization catheters, microcatheters, IVUS catheters, balloon catheters, and others, with thrombectomy catheters leading in 2024 due to widespread use in acute stroke treatment.
By coating type, the market is divided into coated and uncoated catheters, with coated variants dominating due to infection-control priorities in modern healthcare facilities.
Based on lumen, the market is categorized into single-lumen and multi-lumen devices, with multi-lumen catheters holding the largest share in 2024 owing to their ability to support simultaneous therapeutic administration in ICU and interventional settings.
By end user, hospitals and clinics represent the leading segment, driven by investments in neuro-interventional infrastructure and expanding procedural capacity.
The MEA neurovascular catheters market report (2025–2033) provides detailed analysis across market size, forecasts, trends, competitive landscape, regulatory environment, and regional developments. It covers key countries including Turkiye, the UAE, Saudi Arabia, Bahrain, Oman, Egypt, South Africa, Algeria, Nigeria, Kuwait, and Qatar, with Turkiye accounting for the largest share in 2024.
Market dynamics vary significantly across the region. Turkiye and Saudi Arabia lead adoption due to advanced hospital systems and established stroke centers, particularly in major cities such as Riyadh and Jeddah. The UAE demonstrates strong uptake supported by high-end tertiary care hospitals and advanced imaging infrastructure. Egypt shows growing momentum with expanding neuro-interventional capabilities in major urban centers such as Cairo and Alexandria. South Africa and other Sub-Saharan markets are gradually adopting advanced catheter technologies, primarily within private healthcare networks and urban hospitals.
Despite differences in healthcare infrastructure and funding, rising stroke incidence, aging populations, and ongoing healthcare modernization initiatives continue to drive demand across MEA. Hospitals remain the dominant end users, while diagnostic imaging centers and specialized tertiary hospitals are emerging as secondary adopters of neurovascular catheter technologies.